FDA Shares Company-Initiated Recall on Disposable Duodenoscope Endcaps

Public Health

FDA Shares Company-Initiated Recall on Disposable Duodenoscope Endcaps

A detached endcap may cause obstruction requiring urgent removal or lead to burns caused by an uncovered distal end.

The U.S. Food and Drug Administration posted on its medical device database a Class 2 recall on single-use distal covers for duodenoscopes that was initiated by global healthcare company Olympus.

The recall was initiated by Olympus on April 18 and posted to an FDA database on May 19. Recall notification letters were sent to customers on April 23 instructing customers to “immediately locate and no longer use” the original design of model MAJ-2315.

“Correct application and inspection of the distal cover before the procedure is critical,” the letter also states. “In addition, inspection of the distal end after the procedure is also important.”

The recalled distal covers may cause mucosal injury, according to the database posting. The recalled product possesses the risk of becoming detached from the duodenoscopes during use, which may lead to the risk of aspiration or inhalation. Additionally, a detached endcap may cause obstruction requiring urgent removal or lead to burns caused by an uncovered distal end.

Earlier this year, the FDA issued its third warning letter in a six-month span to Olympus. It stated that the endoscope manufacturer received a 2020 complaint that "a patient sustained esophageal trauma" and "tissue from the esophagus was caught up in the distal tip of the device," which was associated with “cracked caps.”

Additionally, the letter stated that since November 2020 Olympus had received approximately 160 complaints describing cases where distal end covers “dropped out.” Olympus, according to the FDA, has failed to establish and maintain procedures for implementing corrective and preventive action.

“Olympus’ continued failure to meet FDA requirements demonstrates a troubling disregard for patient safety,” Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, said in a March news release.

An Olympus spokesperson issued a statement to the New York Times that same month saying that the company had moved to address the deficiencies outlined by the FDA but would “further evaluate these actions” and “expand those efforts.”

More Gastroenterology Articles
How to Prevent ‘Adverse Events’ with New Duodenoscope Models
Patient Safety
A medical device safety experts explains two health risks when disposable endcaps are not properly attached to duodenoscopes.
How Biofilm Mimics a City
Prevention Challenges
People choose to live in cities for a range of benefits including diversity, skills specialization, and food and water access. Bacteria thrive within biofilm for similar reasons.
More From Single-Use Endoscopy
What Do Nurses and Technicians Think About Single-Use Endoscopes?

Preventing Infection

A survey of the professionals tasked with cleaning scopes yielded overwhelming results

Standardizing IFUs would simplify life for sterile processors.

Patient Safety

Expert: Medical device IFUs should be standardized like labels on cereal, soda and chips are.

How to Stop the Cycle of ‘Reactive Repairs’ on Endoscopes

Prevention Challenges

They are costly, add stress for staff and put patients at risk.